Home/Filings/4/0001055726-22-000026
4//SEC Filing

Miller Ann Calby 4

Accession 0001055726-22-000026

CIK 0001055726other

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 4:15 PM ET

Size

7.2 KB

Accession

0001055726-22-000026

Insider Transaction Report

Form 4
Period: 2022-03-21
Transactions
  • Exercise/Conversion

    Common Stock

    2022-03-21+4,27329,534 total
  • Exercise/Conversion

    Restricted Stock Unit

    2022-03-214,2730 total
    Common Stock (4,273 underlying)
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,821 restricted stock units is as follows: 4,274 shares vested on March 21, 2020; 4,274 shares vested on March 21, 2021; 4,273 shares vested on March 21, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Issuer

INOVIO PHARMACEUTICALS, INC.

CIK 0001055726

Entity typeother

Related Parties

1
  • filerCIK 0001771423

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:15 PM ET
Size
7.2 KB